Key Takeaways Eli Lilly received FDA approval for a drug to help treat Alzheimer’s on Tuesday after studies showed it…
Read More »Eli
Key Takeaways Novo Nordisk and Eli Lilly shares lost ground Tuesday after U.S. President Joe Biden and Senator Bernie Sanders…
Read More »The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class…
Read More »Key Takeaways Eli Lilly is partnering with ChatGPT maker OpenAI to use artificial intelligence to develop new treatments to combat…
Read More »Key Takeaways ResMed shares fell sharply in intraday trading Monday following the release of clinical trial data from Eli Lilly…
Read More »Key Takeaways Eli Lilly shares rose in extended-hours trading on Monday after a panel of independent advisors unanimously recommended the…
Read More »Key Takeaways Eli Lilly reported its current treatment for ulcerative colitis, Omvoh, was effective in helping those with Crohn’s disease.…
Read More »Key Takeaways The Dow, S&P 500, and Nasdaq were little changed at midday Tuesday, May 21, 2024 as the market…
Read More »Tom Brady was roasted on Netflix on Sunday night. Peyton Manning made a surprise appearance to razz his longtime rival,…
Read More »Key Takeaways U.S. equities dropped at midday as the market reacted to the latest earnings news and a report showing…
Read More »